Lutz, FLNCT06398626Now EnrollingIRB Ready

Colitis, Ulcerative Clinical Trial in Lutz, FL

Access cutting-edge colitis, ulcerative treatment through this clinical trial at a research site in Lutz. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this Lutz location

Preparing your pre-screening questions…

Expert Care in Lutz

Access colitis, ulcerative specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colitis, ulcerative treatment provided free

Apply for This Lutz Location

Check if you qualify for this colitis, ulcerative clinical trial in Lutz, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lutz

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lutz site if eligible
  4. 4Begin participation

About This Colitis, Ulcerative Study in Lutz

The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice according to the physician and they have not previously taken etrasimod. All patients will be prescribed etrasimod according to standard of care. Tests and doctor visits will be conducted according to standard of care with the exception of health questionnaires about ulcerative colitis symptoms. These questionnaires will be completed by patients at various timepoints during the study using their mobile phone, tablet, or computer. The study is 52 weeks with 28 days of safety follow up. The effects of etrasimod will be analyzed for each patient comparing their disease activity prior to the start of etrasimod.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

Age ≥ 18 years and \< 65 years at baseline
Patients with confirmed diagnosis of UC who are prescribed etrasimod for moderately to severely active UC
Evidence of a personally signed and dated ICD indicating that the patient (or a legally acceptable representative)has been informed of all pertinent aspects of the study

Exclusion Criteria

The presence of clinical findings suggestive of Crohn's disease
Severe extensive colitis evidenced by:
Physician judgement that the patient is likely to require hospitalization for medical or surgical intervention of any kind for UC (e.g., colectomy) within 12 weeks
Current evidence of acute severe UC, fulminant colitis, or toxic megacolon
Patients with a stoma or planned UC surgical intervention requiring hospitalization
Prior/Concomitant Therapy:
Any previous exposure to etrasimod, including participation in the etrasimod clinical program
Any co-medication with one of the following conventional therapies: methotrexate or a thiopurine (azathioprine, mercaptopurine, or tioguanine)
Any co-medication with one of the following advanced therapies for UC: biologics (a TNF, integrin or cytokine antagonist; JAKi \[filgotinib, tofacitinib, or upadacitinib\]) or with any other S1P receptor modulator
Unwillingness or inability to download the web-based tool to complete ePROs on a personal device or not capable of using the web-based tool
Investigator site staff or Pfizer employees directly involved in the conduct of the study, site staff otherwise supervised by the investigator, and their respective family

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lutz?

Yes, this clinical trial (NCT06398626) has an active research site in Lutz, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colitis, Ulcerative Treatment Options in Lutz, FL

If you're searching for colitis, ulcerative treatment options in Lutz, FL, this clinical trial (NCT06398626) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lutz research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colitis, ulcerative specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colitis, ulcerative clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Lutz, FL

See all rheumatoid arthritis clinical trials recruiting in Lutz — not just this study.

Browse Rheumatoid Arthritis Trials in Lutz

Ready to Join in Lutz?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lutz, FL